Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Therapies02:49

Cancer Therapies

10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Cancer Therapies02:49

Cancer Therapies

2.9K
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer-Randomized SIGNAL Clinical Trial.

Cancers·2026
Same author

A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses.

bioRxiv : the preprint server for biology·2026
Same author

Re-envisioning the North American Biodosimetry Assessment Networking Group.

Disaster medicine and public health preparedness·2026
Same author

Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS).

Annals of surgical oncology·2025
Same author

The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer.

NPJ breast cancer·2025
Same author

Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures.

iScience·2025

Related Experiment Video

Updated: Mar 13, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Radiotherapy: Changing the Game in Immunotherapy.

Sandra Demaria1, C Norman Coleman2, Silvia C Formenti1

  • 1Department of Radiation Oncology, Weill Cornell Medicine, 1300 York Ave, Box 169, New York, NY 10065.

Trends in Cancer
|October 25, 2016
PubMed
Summary

Immune checkpoint inhibitors (ICIs) treat cancer by activating anti-tumor T cells in "hot" tumors. Radiotherapy may convert "cold" tumors into responsive ones, acting as a game changer for immunotherapy.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Related Experiment Videos

Last Updated: Mar 13, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Area of Science:

  • Oncology
  • Immunology
  • Radiation Oncology

Background:

  • Immune checkpoint inhibitors (ICIs) are effective cancer treatments, but efficacy relies on pre-existing anti-tumor immune responses within tumors.
  • Tumors with significant lymphocytic infiltration ("hot" tumors) respond to ICIs, while those lacking infiltration ("cold" tumors) are typically resistant.
  • Radiotherapy (RT) shows preclinical promise in sensitizing resistant tumors to ICIs by recruiting anti-tumor T cells.

Purpose of the Study:

  • To review the evidence supporting radiotherapy as a strategy to enhance immunotherapy efficacy.
  • To explore the potential of radiotherapy in converting immunologically "cold" tumors into responsive ones.
  • To propose a framework for clinical studies investigating the combination of radiotherapy and immunotherapy.

Main Methods:

  • Review of preclinical data on the interaction between radiotherapy and anti-tumor immunity.
  • Analysis of clinical studies evaluating the combination of radiotherapy and immune checkpoint inhibitors.
  • Synthesis of evidence regarding radiotherapy's role in modulating the tumor microenvironment.

Main Results:

  • Preclinical studies suggest radiotherapy can recruit T cells to tumors, potentially overcoming resistance to immunotherapy.
  • Clinical evidence demonstrating radiotherapy's ability to convert "cold" tumors into responsive ones remains limited but is an active area of investigation.
  • Radiotherapy is proposed not just as an enhancer but as a potential "game changer" in overcoming immunotherapy resistance.

Conclusions:

  • Radiotherapy holds significant potential to enhance the efficacy of immune checkpoint inhibitors.
  • Further clinical research is crucial to validate radiotherapy's role in converting refractory "cold" tumors into treatable "hot" tumors.
  • A strategic approach is needed to test and optimize the combination of radiotherapy and immunotherapy for broader cancer treatment applications.